日本のドライアイ症候群市場レポート：疾患タイプ、薬剤タイプ、製品タイプ、流通チャネル、地域別、2025年～2033年

日本のドライアイ症候群の市場規模は2024年に1億4,500万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに1億9,700万米ドルに達し、2025年から2033年にかけて3.5%の成長率（CAGR）を示すと予測しています。

本レポートで扱う主な質問

• 日本のドライアイ症候群市場はこれまでどのように推移し、今後どのように推移するのか？
• COVID-19が日本のドライアイ症候群市場に与えた影響は？
• 主要な地域市場とは？
• 疾患タイプ別の市場内訳は？
• 薬剤タイプ別の市場内訳は？
• 製品別の市場内訳は？
• 販売チャネル別の市場内訳は？
• 業界のバリューチェーンにおける様々な段階とは？
• 業界の主要な促進要因と課題は何か？
• 日本のドライアイ症候群市場の構造と主要プレーヤーは？
• 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
• 市場推定
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 日本のドライアイ症候群市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：疾患タイプ別

• 蒸発性ドライアイ症候群
• 涙液性ドライアイ症候群

第7章 市場内訳：薬剤タイプ別

• 抗炎症薬
• 潤滑点眼薬
• 自己血清点眼薬

第8章 市場内訳：製品別

• 液滴
• ゲル
• 液体ワイプ
• 眼軟膏
• その他

第9章 市場内訳：流通チャネル別

• 病院薬局
• 小売薬局
• オンライン薬局

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 政策と規制状況

第15章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル

List of Figures

• Figure 1: Japan: Dry Eye Syndrome Market: Major Drivers and Challenges
• Figure 2: Japan: Dry Eye Syndrome Market: Sales Value (in Million USD), 2019-2024
• Figure 3: Japan: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2024
• Figure 4: Japan: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2024
• Figure 5: Japan: Dry Eye Syndrome Market: Breakup by Product (in %), 2024
• Figure 6: Japan: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2024
• Figure 7: Japan: Dry Eye Syndrome Market: Breakup by Region (in %), 2024
• Figure 8: Japan: Dry Eye Syndrome Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 9: Japan: Dry Eye Syndrome (Evaporative) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 10: Japan: Dry Eye Syndrome (Evaporative) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 11: Japan: Dry Eye Syndrome (Aqueous) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Japan: Dry Eye Syndrome (Aqueous) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Japan: Dry Eye Syndrome (Anti-inflammatory Drugs) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Japan: Dry Eye Syndrome (Anti-inflammatory Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Japan: Dry Eye Syndrome (Lubricant Eye Drops) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Japan: Dry Eye Syndrome (Lubricant Eye Drops) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: Japan: Dry Eye Syndrome (Autologous Serum Eye Drops) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: Japan: Dry Eye Syndrome (Autologous Serum Eye Drops) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: Japan: Dry Eye Syndrome (Liquid Drops) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Japan: Dry Eye Syndrome (Liquid Drops) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: Japan: Dry Eye Syndrome (Gel) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: Japan: Dry Eye Syndrome (Gel) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: Japan: Dry Eye Syndrome (Liquid Wipes) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: Japan: Dry Eye Syndrome (Liquid Wipes) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Japan: Dry Eye Syndrome (Eye Ointment) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: Japan: Dry Eye Syndrome (Eye Ointment) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: Japan: Dry Eye Syndrome (Other Product Types) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: Japan: Dry Eye Syndrome (Other Product Types) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: Japan: Dry Eye Syndrome (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: Japan: Dry Eye Syndrome (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: Japan: Dry Eye Syndrome (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: Japan: Dry Eye Syndrome (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: Japan: Dry Eye Syndrome (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: Japan: Dry Eye Syndrome (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: Japan: Dry Eye Syndrome Industry: SWOT Analysis
• Figure 36: Japan: Dry Eye Syndrome Industry: Value Chain Analysis
• Figure 37: Japan: Dry Eye Syndrome Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Japan: Dry Eye Syndrome Market: Key Industry Highlights, 2024 and 2033
• Table 2: Japan: Dry Eye Syndrome Market Forecast: Breakup by Disease Type (in Million USD), 2025-2033
• Table 3: Japan: Dry Eye Syndrome Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
• Table 4: Japan: Dry Eye Syndrome Market Forecast: Breakup by Product (in Million USD), 2025-2033
• Table 5: Japan: Dry Eye Syndrome Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
• Table 6: Japan: Dry Eye Syndrome Market: Competitive Structure
• Table 7: Japan: Dry Eye Syndrome Market: Key Players

The Japan dry eye syndrome market size reached USD 145 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 197 Million by 2033, exhibiting a growth rate (CAGR) of 3.5% during 2025-2033.

Dry eye syndrome, or keratoconjunctivitis sicca (KCS), is a medical disorder that occurs due to the lack of adequate moisture or lubrication on the surface of the eyes. It is a chronic ailment characterized by redness, itching, aching, discomfort, pain, burning sensation in the eyes and photophobia. It can be caused due to extensive computer usage, menopause, allergies, deficiency of vitamin A, laser surgeries and autoimmune diseases. The syndrome can be treated by administering artificial tears, lacrimal plugs, medications and various surgical procedures. It can also be prevented by wearing wraparound sunglasses or other protective eyewear.

The growth in the Japan dry eye syndrome market can be attributed to the rising geriatric population. Dry eye syndrome is also widely associated with various medical conditions, such as diabetes, Sjogren's syndrome, arthritis, thyroid disorders, lupus and scleroderma that is highly prevalent among the elderly population. In addition to this, the increasing inclination toward activities requiring excessive screen time is also impacting the occurrence of the syndrome. These activities cause a high strain on the eyes, leading to fatigue and lack of lubrication. Moreover, various product innovations, such as the development of functional visual acuity meter devices that can measure changes in continuous visual acuity over time, are providing a thrust to the market growth. In line with this, the widespread adoption of hyaluronic acid that assists in retaining moisture and effectively treating dry eye syndrome is positively impacting the market growth. Other factors, including significant improvements in diagnostic technologies, along with rising healthcare expenditure capacities of the masses, are creating a positive outlook for the market.

Key Market Segmentation:

Breakup by Disease Type:

• Evaporative Dry Eye Syndrome
• Aqueous Dry Eye Syndrome

Breakup by Drug Type:

• Anti-inflammatory Drugs
• Lubricant Eye Drops
• Autologous Serum Eye Drops

Breakup by Product:

• Liquid Drops
• Gel
• Liquid Wipes
• Eye Ointment
• Others

Breakup by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key Questions Answered in This Report:

• How has the Japan dry eye syndrome market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan dry eye syndrome market?
• What are the key regional markets?
• What is the breakup of the market based on the disease type?
• What is the breakup of the market based on the drug type?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the distribution channel?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the Japan dry eye syndrome market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Japan Dry Eye Syndrome Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Disease Type

• 6.1 Evaporative Dry Eye Syndrome
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Aqueous Dry Eye Syndrome
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Drug Type

• 7.1 Anti-inflammatory Drugs
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Lubricant Eye Drops
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Autologous Serum Eye Drops
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Product

• 8.1 Liquid Drops
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Gel
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Liquid Wipes
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Eye Ointment
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Distribution Channel

• 9.1 Hospital Pharmacies
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Retail Pharmacies
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Online Pharmacies
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Policy and Regulatory Landscape

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players